Using a 100 µL sample size, most of the tested analytes were recovered at 70 percent or greater. The analytical response for the extracted analytes with high matrix effects was sufficient to achieve adequate recoveries and LODs. This method, therefore, supports the use of ISOLUTE® SLE+ for the screening of urine samples for various illicit and prescribed drugs.
Codeine, hydrocodone, oxycodone, norcodeine, oxymorphone, 6-acetyl codeine, alprazolam, clonazepam, diazepam, flunitrazepam, nitrazepam, oxazepam, temazepam, dextromethorphan, buprenorphine, norbuprenorphine, fentanyl, EDDP, benzoylecgonine, tetrahydrocannabinol, normeperidine, naltrexone, hydromorphone, propoxyphene, pentazocine, amphetamine, norfentanyl, MDEA, butalbital, pentobarbital, phenobarbital, secobarbital, 11-nor-9 –carboxy- Δ9-tetrahydrocannabinol, and d3-11-hydroxy-tetrahydrocannabinol.
Download the application note below.
New Method for Determination of Voriconazole in Plasma
Biotage Receives the SwedenBIO Award 2019
New Method for Determination of 1, 4-Dioxane in Drinking Water
New Application Note for Determination of Mycophenolic Acid
Two Alternative Approaches to the Extraction of a Suite of Regulated Veterinary Growth Promoters